Pluribus Labs’s Stryker SYK Stock Holding History

Pluribus Labs’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,354	Closed	-$362K	–	202
2021 Q4	$362K	Buy	+1,354	New	+$355K	0.38%	97

Other funds holding SYK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pluribus Labs's SYK Position: Q1 2022 in Review

Pluribus Labs sold out of Stryker (SYK) in Q1 2022, closing a stake of 1,354 shares — an estimated $362K sold.

Pluribus Labs first reported a position in SYK in Q4 2021 and held it in 1 quarter. The position peaked at $362K in Q4 2021. 1,671 funds tracked by Wall St. Rank hold SYK as of Q1 2022.

Pluribus Labs reported no remaining Stryker position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 1,354 Stryker shares in Q1 2022, an estimated $362K.
Pluribus Labs first reported a position in Stryker in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Stryker position peaked at $362K in Q4 2021.
1,671 funds tracked by Wall St. Rank held Stryker as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.